Postprandial effect of krill oil supplementation in healthy female subjects

Phase 3

Completed

• Conditions: Cardiovascular disease; Metabolic and Endocrine disorders; Cardiovascular - Coronary heart disease; Metabolic and Endocrine - Metabolic disorders

• Registration Number: ACTRN12615000620527
• Lead Sponsor: Victoria University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 15

Inclusion Criteria

Healthy females aged 18-45 years and have not experienced menopause, body mass index (BMI) between 20 and 30 (kg/m2).

Exclusion Criteria

Cigarette smoker; all types of heart, liver or kidney disease, diabetes; pregnancy; lactating; medications of cholesterol lowering, antihypertension, anti-inflammation, anti-coagulation or anti-depression; omega-3 or antioxidant supplements in the past four weeks prior to the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in plasma fatty acid composition. This will be analysed using Gas Chromatography[At hours 1-5 post intervention for each dietary oil supplement]

Secondary Outcome Measures

Name	Time	Method
Changes in blood lipid profiles including triglycerides, cholesterol, HDL-C and LDL-C will be assessed using plasma sample with enzyme<br>immunoassay testing kits.[At hours 1-5 post intervention for each dietary oil supplement.];Inflammatory bio-markers including CRP, IL-1 and IL-6 will be analysed using plasma sample with<br>enzyme immunoassay testing kits.[5 hours post intervention]